Invesco’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
6,388
-1,287
-17% -$37.8K ﹤0.01% 3555
2026
Q1
$237K Buy
+7,675
New +$189K ﹤0.01% 3426
2025
Q1
Sell
-128,178
Closed -$5.92M 3817
2024
Q4
$5.92M Buy
+128,178
New +$5.42M ﹤0.01% 2162
2022
Q2
Sell
-952
Closed -$15K 4164
2022
Q1
$15K Buy
952
+3
+0.3% +$62 ﹤0.01% 3995
2021
Q4
$44K Sell
949
-620
-40% -$35.6K ﹤0.01% 3991
2021
Q3
$105K Buy
1,569
+154
+11% +$12.6K ﹤0.01% 3931
2021
Q2
$151K Buy
+1,415
New +$168K ﹤0.01% 3837
2020
Q1
Sell
-11,927
Closed -$2.88M 3738
2019
Q4
$2.88M Hold
11,927
﹤0.01% 2485
2019
Q3
$2.02M Sell
11,927
-458
-4% -$104K ﹤0.01% 2631
2019
Q2
$2.42M Buy
12,385
+459
+4% +$99K ﹤0.01% 2604
2019
Q1
$3.15M Sell
11,926
-18
-0.2% -$3.29K ﹤0.01% 2318
2018
Q4
$2.39M Sell
11,944
-71
-0.6% -$21.6K ﹤0.01% 2428
2018
Q3
$7.48M Sell
12,015
-600
-5% -$266K ﹤0.01% 1904
2018
Q2
$4.32M Buy
+12,615
New +$4.55M ﹤0.01% 2227

Other funds holding TECX

Invesco's TECX Position: Q2 2026 in Review

Invesco reduced its Tectonic Therapeutic (TECX) stake by 17% in Q2 2026, selling an estimated $37.8K and leaving 6,388 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3555.

Invesco first reported a position in TECX in Q2 2018 and has held it in 14 quarters since. The position peaked at $7.48M in Q3 2018. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Invesco held 6,388 shares of Tectonic Therapeutic worth $220K as of Q2 2026.
  • Invesco sold 1,287 Tectonic Therapeutic shares in Q2 2026, an estimated $37.8K.
  • Tectonic Therapeutic made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3555 holding.
  • Invesco first reported a position in Tectonic Therapeutic in Q2 2018 and has held it in 14 quarters since.
  • Invesco's Tectonic Therapeutic position peaked at $7.48M in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.